Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
Stat
Wed, 04/12/23 - 10:26 pm
Parkinson's Disease
Michael J Fox
FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
Tue, 03/21/23 - 09:56 pm
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents
Cerevel blames Covid for delayed neuroscience studies, says president is leaving
Endpoints
Fri, 02/24/23 - 09:12 am
Cerevel Therapeutics
COVID-19
epilepsy
Parkinson's Disease
darigabat
CVL-871
Working its way through a CRL on lead drug, Supernus taps $150M loan
Endpoints
Wed, 02/15/23 - 06:17 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Inhibikase, FDA find common ground to lift hold on Parkinson's drug
Fierce Biotech
Wed, 01/25/23 - 10:43 pm
Inhibikase Therapeutics
Parkinson's Disease
IkT-148009
clinical trials
Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial
Fierce Biotech
Thu, 01/19/23 - 10:03 am
Ipsen
IRLAB
clinical trials
Parkinson's Disease
mesdopetam
Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab
Fierce Biotech
Mon, 01/9/23 - 10:34 am
Voyager Therapeutics
Neurocrine
capsids
CNS
Parkinson's Disease
CuraSen reports positive data from Parkinson’s disease oral therapy trial
Clinical Trials Arena
Tue, 12/20/22 - 10:58 am
CuraSen
clinical trials
CST-103
Parkinson's Disease
FDA accepts Amneal’s NDA for IPX203 to treat Parkinson’s disease
Pharmaceutical Business Review
Mon, 11/14/22 - 10:31 am
Amneal
FDA
IPX203
Parkinson's Disease
NRG Therapeutics Scores $18M to Target Mitochondrial Dysfunction in Parkinson's, ALS
BioSpace
Thu, 11/10/22 - 10:25 am
NRG Therapeutics
funding
Parkinson's Disease
ALS
Inhibikase stock sinks on FDA's unexpected clinical hold for lead asset's Parkinson's trial
Fierce Biotech
Mon, 11/7/22 - 10:44 am
Inhibikase Therapeutics
Parkinson's Disease
IkT-148009
FDA spurns Supernus for Parkinson's drug, noting application issues 'across several areas'
Endpoints
Mon, 10/10/22 - 06:47 pm
Supernus Pharmaceuticals
FDA
Parkinson's Disease
SPN-830
Biogen, Denali begin late-stage testing of Parkinson’s drug
BioPharma Dive
Mon, 10/3/22 - 11:28 pm
Biogen
Denali Therapeutics
Parkinson's Disease
clinical trials
BIIB122
Qiagen to Develop Companion Dx for New Parkinson's Drug
Medical Devices and Diagnostics Industry
Thu, 09/22/22 - 10:50 am
Qiagen
companion diagnostics
Parkinson's Disease
Medtech
Neuron23
Amneal asks FDA to approve another new formulation of Parkinson’s combo drug
Endpoints
Tue, 09/6/22 - 10:42 am
Amneal
Parkinson's Disease
carbidopa/levodopa
IPX203
Amneal submits NDA to US FDA for Parkinson’s disease treatment
Pharmaceutical Business Review
Thu, 09/1/22 - 10:31 am
Amneal
FDA
Parkinson's Disease
IPX203
Annovis Bio doses first subject in Phase III Parkinson’s trial
Clinical Trials Arena
Thu, 08/25/22 - 10:49 am
Annovis Bio
clinical trials
buntanetap
Parkinson's Disease
Inhibikase doses first subject in Phase IIa Parkinson’s treatment trial
Clinical Trials Arena
Wed, 08/24/22 - 10:38 am
Inhibikase Therapeutics
clinical trials
Parkinson's Disease
IkT-148009
Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s
Pharmaforum
Mon, 07/18/22 - 09:53 am
Kyowa Kirin
KW-6356
clinical trials
Parkinson's Disease
Intercept, Annovis and Biohaven Advance Late Phase Trials
BioSpace
Mon, 07/11/22 - 12:00 am
Intercept Pharma NASH
Annovis
buntanetap
Parkinson's Disease
Biohaven
taldefgrobep alfa
SMA
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »